Aktis Oncology, Inc. (AKTS) stock
Close on Nov 13, 2026Market cap $924.40MP/E –Yield –
Aktis Oncology statistics
41 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 29, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.01
- 2.22
Share statisticsIndustry
- Shares Change (QoQ)
- 0.86%
- 0.50%
- Float
- 28M
- 49M
- Shares Held by Insiders
- 49.6%
- 11.7%
- Shares Held by Institutions
- 61.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 2.60%
- -0.80%
- Short % of Float
- 15.8%
- 9.01%
- Short % of Shares Outstanding
- 7.96%
- 6.30%
- Days to Cover
- 16.02
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $34.19
- –
- 52-Week Low
- $13.96
- –
- 20-Day Moving Average
- $16.05
- –
- 50-Day Moving Average
- $18.54
- –
- 200-Day Moving Average
- $20.78
- –
- Average True Range (14)
- $1.06
- –
- Price Change (1 Week)
- 5.06%
- -1.15%
- Price Change (1 Month)
- 3.81%
- -4.87%
- Price Change (3 Months)
- -32.8%
- -21.0%
- Price Change (6 Months)
- -15.0%
- -20.6%
- Average Volume (10 Days)
- 412,012
- –
- Average Volume (20 Days)
- 340,103
- –
- Average Volume (90 Days)
- 365,341
- –
- Relative Volume
- 0.67
- 0.70
- Relative Strength Index (14)
- 48.5
- 43.4
- Volatility (1 Year)
- 67.5%
- 80.1%
Financial positionIndustry
- Current Ratio
- 14.22
- 3.30
- Quick Ratio
- 14.02
- 2.39
EfficiencyIndustry
- Employee Count
- 79
- 74
Balance sheetIndustry
- Net Cash (Debt)
- $492.90M
- $17.76M
- Net Cash Per Share
- $8.86
- $0.80
- Equity (Book Value)
- $458.87M
- $53.89M
- Book Value Per Share
- $8.25
- $1.50
- Tangible Book Value
- $458.87M
- $27.13M
- Working Capital
- $464.73M
- $79.99M
Scores and fair valueIndustry
- Altman Z-Score
- 7.98
- 0.23
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AKTS | S&P 500 | Difference | AKTS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.1% | -3.0% | +2.9 pts | ||
| 3 months | -30.1% | -2.8% | −27.4 pts | ||
| Year to date | +41450.0% | +11.5% | +41438.5 pts | ||
| 1 year | +41450.0% | +13.5% | +41436.5 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M AKTS shares were sold short on Oct 30, 2026, up 2.6% from the previous report, or 15.79% of the shares available to trade. At recent volumes it would take 16.0 days to buy them back. Over the last 20 sessions, 80.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,425,903 | +2.6% | 276,236 | 16.0 |
| Oct 15, 2026 | 4,313,744 | -8.5% | 382,800 | 11.3 |
| Sep 30, 2026 | 4,715,294 | +45.0% | 645,721 | 7.3 |
| Sep 15, 2026 | 3,252,475 | +2.4% | 281,999 | 11.5 |
| Aug 31, 2026 | 3,175,040 | -7.9% | 306,432 | 10.4 |
| Aug 14, 2026 | 3,447,126 | -0.7% | 229,684 | 15.0 |
| Jul 31, 2026 | 3,470,122 | -7.2% | 270,289 | 12.8 |
| Jul 15, 2026 | 3,741,161 | +13.1% | 597,286 | 6.3 |
| Jun 30, 2026 | 3,306,972 | +13.5% | 662,226 | 5.0 |
| Jun 15, 2026 | 2,913,924 | +9.3% | 251,958 | 11.6 |
| May 29, 2026 | 2,666,881 | +5.5% | 145,042 | 18.4 |
| May 15, 2026 | 2,527,598 | -1.7% | 151,236 | 16.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?